VIE Equity Snapshot

KRKG Weekly Equity Report

Krka, d. d.

Interactive chart JSON snapshot
Latest Close 258.5 EUR 12 Jun 2026
1W Return 0.4% latest completed week
4W Return 0.0% short-term follow-through
12W Return 12.9% quarterly tape
Trend Breadth 0.0% 0 of 15 weeks active
Volume Ratio - vs 13-week average
Company Brief

What the company does

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company offers prescription pharmaceuticals for cardiovascular, central nervous system, gastrointestinal tract, pain, diabetes, and other therapeutic areas. It also provides non-prescription products for cough, cold, cerebral, peripheral circulation, gastrointestinal tract, metabolism, and other therapeutic areas, as well as analgesics, vitamins, minerals, and vasoprotectives. In addition, the company offers animal health products, including antiparasitics, antimicrobials, and other products. Further, it provides health resort …

Snapshot

What the weekly tape is saying

KRKG closed the latest completed week at 258.5 EUR. The 4-week return is 0.0% and the 12-week return is 12.9%. Trend Signal is inactive, Market Dynamics is 0.00. Setup signature: Balanced read with a 42/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -
Volume -
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 0 Persistence of active Trend Signal over the last year and current streak.
Momentum 62 Blend of 4-week and 12-week follow-through.
Dynamics 50 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 50 Relative leadership and short-term RS change.
Volume 0 Participation compared with the 13-week volume baseline.
Risk Control 89 Drawdown and recent weekly volatility pressure.

16-week signal tape

6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
-
Vs Trend Line
-
Fair Value
244.6 EUR
Vs Fair Value
5.7%
52W High
265.0 EUR
52W Low
224.0 EUR
Drawdown
-2.5%
Range Position
84.1%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 0.4%
4W 0.0%
12W 12.9%
26W -
52W -

Trend read

Active Streak
0 weeks
52W Active Weeks
0
52W Active Breadth
0.0%
Sector Scope
AT Healthcare
Sector Rank
38 of 112
Sector Percentile
66.7%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.00
4W MD Change
-
Relative Strength
-
4W RS Change
-
Expectation
Positive
Probability
63.03%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
0
13W Average
9
52W Average
8
Vs 13W
-
Vs 52W
-
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
1.3%
52W Volatility
1.3%
Upside Weeks
9
Downside Weeks
3
Downside Breadth
21.4%
Avg Gain / Loss
1.6% / -0.9%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
VIE
Country
AT
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
EUR
Market Cap
7.7B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Market Dynamics is negative, which weakens the current setup.

Watch next

  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 258.5 EUR 0.4% - 244.6 EUR 0.00 - 0 Off
5 Jun 2026 257.5 EUR 1.2% - 243.6 EUR 0.00 - 20 Off
29 May 2026 254.5 EUR -1.5% - 242.5 EUR 0.00 - 0 Off
22 May 2026 258.5 EUR 0.0% - 241.5 EUR 0.00 - 40 Off
15 May 2026 258.5 EUR 2.8% - 240.0 EUR 0.00 - 0 Off
8 May 2026 251.5 EUR 2.9% - 238.2 EUR 0.00 - 0 Off
1 May 2026 244.5 EUR -0.2% - 236.7 EUR 0.00 - 0 Off
24 Apr 2026 245.0 EUR 0.2% - 235.7 EUR 0.00 - 40 Off
17 Apr 2026 244.5 EUR 1.9% - 234.4 EUR 0.00 - 0 Off
10 Apr 2026 240.0 EUR 2.1% - 232.7 EUR 0.00 - 0 Off
3 Apr 2026 235.0 EUR 2.2% - 231.2 EUR 0.00 - 0 Off
27 Mar 2026 230.0 EUR 0.4% - 230.2 EUR 0.00 - 20 Off
20 Mar 2026 229.0 EUR -0.9% - 230.3 EUR - - 0 Off
13 Mar 2026 231.0 EUR 0.0% - 231.0 EUR - - 1 Off